Clicky

TransMedics Group, Inc.(TMDX)

Description: TransMedics, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. The company offers Organ Care System (OCS), an integrated, compact, portable preservation technology that addresses unmet need for organs for transplantation. Its Organ Care System preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure. Its Organ Care System incudes OCS LUNG, a portable perfusion, ventilation, and monitoring system that maintains organs in a near physiologic state and enables surgeons to perfuse and ventilate the organ between the donor and recipient sites; OCS Heart, a portable heart perfusion system that helps to maintain organs in a warm functioning state outside of the body; and OCS Liver, a portable perfusion and monitoring system that maintains organs in a near physiologic state. The company offers its products in the United States and internationally. TransMedics, Inc. is headquartered in Andover, Massachusetts. TransMedics, Inc. is a subsidiary of Transmedics Group, Inc.


Keywords: Medicine Disease Surgery Medical Technology Transplantation Transplantation Medicine Organs Organ Transplantation Perfusion Organ Failure Organ Transplant Stage Medical Technology Liver Failure Lung Transplantation Organ Organ Donation

Home Page: www.transmedics.com

TMDX Technical Analysis

200 Minuteman Road
Andover, MA 01810
United States
Phone: 978 552 0900


Officers

Name Title
Dr. Waleed H. Hassanein M.D. Founder, Pres, MD, CEO & Director
Mr. Stephen Gordon CFO. Treasurer & Sec.
Dr. Tamer I. Khayal M.D. Chief Commercial Officer
Ms. Miriam C. Provost Ph.D. VP of Global Regulatory Affairs
Ms. Laura Damme VP of Clinical Affairs
Mr. John F. Carey VP of Operations
Mr. Mark Anderson Sr. Director of Technology Devel.
Ms. Susan Goodman VP of HR

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 9.9924
Price-to-Sales TTM: 26.4418
IPO Date: 2019-05-02
Fiscal Year End: December
Full Time Employees: 148
Back to stocks